Literature DB >> 11145722

Type 1 diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase (GAD) 65-specific T cells in a transgenic model.

R S Abraham1, L Wen, E V Marietta, C S David.   

Abstract

The genetic factors that contribute to the etiology of type 1 diabetes are still largely uncharacterized. However, the genes of the MHC (HLA in humans) have been consistently associated with susceptibility to disease. We have used several transgenic mice generated in our laboratory, bearing susceptible or resistant HLA alleles, in the absence of endogenous MHC class II (Abetao), to study immune responses to the autoantigen glutamic acid decarboxylase (GAD) 65 and its relevance in determining the association between autoreactivity and disease pathogenesis. Mice bearing diabetes-susceptible haplotypes, HLA DR3 (DRB1*0301) or DQ8 (DQB1*0302), singly or in combination showed spontaneous T cell reactivity to rat GAD 65, which is highly homologous to the self Ag, mouse GAD 65. The presence of diabetes-resistant or neutral alleles, such as HLA DQ6 (DQB1*0602) and DR2 (DRB1*1502) prevented the generation of any self-reactive responses to rat GAD. In addition, unmanipulated Abetao/DR3, Abetao/DQ8, and Abetao/DR3/DQ8 mice recognized specific peptides, mainly from the N-terminal region of the GAD 65 molecule. Most of these regions are conserved between human, mouse, and rat GAD 65. Further analysis revealed that the reactivity was mediated primarily by CD4(+) T cells. Stimulation of these T cells by rat GAD 65 resulted in the generation of a mixed Th1/Th2 cytokine profile in the Abetao/DR3/DQ8, Abetao/DR3, and Abetao/DQ8 mice. Thus, the presence of diabetes-associated genes determines whether immune tolerance is maintained to islet autoantigens, but autoreactivity in itself is not sufficient to induce diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145722     DOI: 10.4049/jimmunol.166.2.1370

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Molecular aspects of type 1 diabetes.

Authors:  M A Kelly; M L Rayner; C H Mijovic; A H Barnett
Journal:  Mol Pathol       Date:  2003-02

2.  HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretion.

Authors:  R C Williams; Y L Muller; R L Hanson; W C Knowler; C C Mason; L Bian; V Ossowski; K Wiedrich; Y F Chen; S Marcovina; J Hahnke; R G Nelson; L J Baier; C Bogardus
Journal:  Diabetologia       Date:  2011-04-12       Impact factor: 10.122

Review 3.  HLA class II molecules influence susceptibility versus protection in inflammatory diseases by determining the cytokine profile.

Authors:  Ashutosh K Mangalam; Veena Taneja; Chella S David
Journal:  J Immunol       Date:  2013-01-15       Impact factor: 5.422

Review 4.  What can the HLA transgenic mouse tell us about autoimmune diabetes?

Authors:  F S Wong; L Wen
Journal:  Diabetologia       Date:  2004-09-02       Impact factor: 10.122

5.  A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes.

Authors:  Wafaa M Bassuny; Kenji Ihara; Yuka Sasaki; Ryuichi Kuromaru; Hitoshi Kohno; Nobuo Matsuura; Toshiro Hara
Journal:  Immunogenetics       Date:  2003-05-16       Impact factor: 2.846

6.  Autoimmune type 1 diabetes genetic susceptibility encoded by human leukocyte antigen DRB1 and DQB1 genes in Tunisia.

Authors:  Mouna Stayoussef; Jihen Benmansour; Abdul-Qader Al-Irhayim; Hichem B Said; Chiheb B Rayana; Touhami Mahjoub; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2009-06-24

Review 7.  Lessons for human diabetes from experimental mouse models.

Authors:  Rohit N Kulkarni; Ariel Zisman
Journal:  Curr Diab Rep       Date:  2003-04       Impact factor: 5.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.